Building Next-Generation Therapeutic Biologics
Profile
Simisco Bioscences is a protein engineering company developing antibody-based therapeutics as novel treatments for cancer and chronic, degenerative and infectious diseases.
Innovative Technology
Using its extensive portfolio of Fabs and scFvs targeting hundreds of disease-associated proteins, Simisco engineers complex multivalent, multi-specific therapeutic-grade molecules as novel drug candidates that modulate target function for therapeutic needs.
Team
Simisco was established by Dr. Sachdev Sidhu, PhD and is now led by an experienced team of scientists and business leaders. With locations in Ontario, Canada; California, USA; and Kerala, India, Simisco’s team brings in a variety of perspectives and talent.